Your browser doesn't support javascript.
loading
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection.
Leal, Lorna; Guardo, Alberto C; Morón-López, Sara; Salgado, Maria; Mothe, Beatriz; Heirman, Carlo; Pannus, Pieter; Vanham, Guido; van den Ham, Henk Jan; Gruters, Rob; Andeweg, Arno; Van Meirvenne, Sonja; Pich, Judit; Arnaiz, Joan Albert; Gatell, Josep M; Brander, Christian; Thielemans, Kris; Martínez-Picado, Javier; Plana, Montserrat; García, Felipe.
Affiliation
  • Leal L; Infectious Diseases Department, Hospital Clínic-HIVACAT, University of Barcelona.
  • Guardo AC; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-HIVACAT, Barcelona.
  • Morón-López S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-HIVACAT, Barcelona.
  • Salgado M; IrsiCaixa AIDS Research Institute - HIVACAT, Badalona.
  • Mothe B; IrsiCaixa AIDS Research Institute - HIVACAT, Badalona.
  • Heirman C; IrsiCaixa AIDS Research Institute - HIVACAT, Badalona.
  • Pannus P; Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel (VUB), Brussels.
  • Vanham G; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • van den Ham HJ; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Gruters R; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Andeweg A; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Van Meirvenne S; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Pich J; Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel (VUB), Brussels.
  • Arnaiz JA; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-HIVACAT, Barcelona.
  • Gatell JM; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-HIVACAT, Barcelona.
  • Brander C; Infectious Diseases Department, Hospital Clínic-HIVACAT, University of Barcelona.
  • Thielemans K; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-HIVACAT, Barcelona.
  • Martínez-Picado J; IrsiCaixa AIDS Research Institute - HIVACAT, Badalona.
  • Plana M; Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel (VUB), Brussels.
  • García F; IrsiCaixa AIDS Research Institute - HIVACAT, Badalona.
AIDS ; 32(17): 2533-2545, 2018 11 13.
Article in En | MEDLINE | ID: mdl-30289805

Full text: 1 Database: MEDLINE Main subject: Dendritic Cells / RNA, Messenger / HIV Infections / AIDS Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Main subject: Dendritic Cells / RNA, Messenger / HIV Infections / AIDS Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article